Skip to content

Rocket Pharmaceuticals, Inc.

RCKT RCKTW

CIK 0001281895

← back to feed
Revenue (TTM)
$0
Q1 May 2026
Net Income (TTM)
−$228.18M
+13.8% YoY Q1 May 2026
EPS Diluted (TTM)
−$2.05
+26.4% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$221.11M
Q1 May 2026
Cash
$49.61M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
109.19M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings